LetterLetter
How Are Rheumatologists Managing Anticyclic Citrullinated Peptide Antibodies–positive Patients Who Do Not Have Arthritis?
KULVEER MANKIA, CHRISTOPHER BRIGGS and PAUL EMERY
The Journal of Rheumatology February 2020, 47 (2) 305-306; DOI: https://doi.org/10.3899/jrheum.190211
KULVEER MANKIA
Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre, Leeds Teaching Hospitals National Health Service (NHS) Trust;
DM, MRCPCHRISTOPHER BRIGGS
Leeds Teaching Hospitals NHS Trust;
MBBSPAUL EMERY
Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and UK NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds,
UK.
MD, FRCPREFERENCES
- 1.↵
- 2.↵
- 3.↵Rheumatoid arthritis in adults: management. NICE guideline [NG100]. [Internet. Accessed October 10, 2019.] Available from: www.nice.org.uk/guidance/ng100
- 4.↵Best practice tariff: early inflammatory arthritis. 2019/20 national tariff. Tariff documents. Annex F: Models used to calculate prices. [Internet. Accessed November 20, 2019.] Available from: improvement.nhs.uk
- 5.↵
- Mankia K,
- Emery P
- 6.↵
- Cope AP
- 7.↵
- Gerlag DM,
- Safy M,
- Maijer KI,
- Tang MW,
- Tas SW,
- Starmans-Kool MJF,
- et al.
- 8.↵
- Nam JL,
- Hensor EM,
- Hunt L,
- Conaghan PG,
- Wakefield RJ,
- Emery P
In this issue
The Journal of Rheumatology
Vol. 47, Issue 2
1 Feb 2020
How Are Rheumatologists Managing Anticyclic Citrullinated Peptide Antibodies–positive Patients Who Do Not Have Arthritis?
KULVEER MANKIA, CHRISTOPHER BRIGGS, PAUL EMERY
The Journal of Rheumatology Feb 2020, 47 (2) 305-306; DOI: 10.3899/jrheum.190211